By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Benzodiazepine > Temazepam

Temazepam

GMJ
Last updated: 02/06/2026 14:30
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|669 words

Temazepam: Complete Drug Profile

What is Temazepam?

Temazepam is a prescription medication belonging to the benzodiazepine class of drugs that acts as a central nervous system depressant. It is primarily prescribed for the short-term treatment of insomnia, particularly for patients who have difficulty falling asleep or staying asleep. As a controlled substance, temazepam requires careful monitoring due to its potential for dependence and abuse.

Uses

Temazepam has several documented medical uses:

  • Insomnia treatment: The primary indication for temazepam is short-term management of sleep disorders, helping patients fall asleep faster and maintain sleep throughout the night.
  • Pre-operative sedation: Sometimes used as a sedative before surgical procedures to reduce anxiety and promote relaxation.
  • Anxiety-related sleep disturbances: May be prescribed for sleep problems specifically caused by anxiety disorders when other treatments are insufficient.
  • Hospital-based sleep management: Used in clinical settings to help patients sleep in unfamiliar or stressful environments.
  • Sleep maintenance disorders: Particularly effective for patients who wake frequently during the night and have trouble returning to sleep.

How it works

Temazepam works by enhancing the activity of gamma-aminobutyric acid (GABA), the brain’s primary inhibitory neurotransmitter. It binds to specific GABA receptors in the brain, increasing the frequency of chloride channel opening, which results in enhanced neuronal inhibition. This action produces sedative, hypnotic, and muscle relaxant effects that promote sleep onset and maintenance.

Side effects

Common side effects include:

Submit Your Paper
GMJ_Submit_Banner
  • Drowsiness and daytime sedation
  • Dizziness and lightheadedness
  • Headache
  • Nausea and gastrointestinal upset
  • Dry mouth
  • Fatigue and weakness
  • Coordination problems
  • Memory impairment or amnesia

Serious side effects requiring immediate medical attention:

  • Severe respiratory depression or difficulty breathing
  • Complex sleep behaviors (sleep-walking, sleep-driving, sleep-eating)
  • Severe allergic reactions including facial swelling
  • Suicidal thoughts or behaviors
  • Severe confusion or disorientation

Warnings and precautions

  • Pregnancy and breastfeeding: Temazepam is classified as pregnancy category X, meaning it should not be used during pregnancy due to risk of birth defects and withdrawal symptoms in newborns. It is also not recommended during breastfeeding.
  • Elderly patients: Older adults are more sensitive to benzodiazepines and face increased risk of falls, cognitive impairment, and prolonged sedation, requiring lower doses and careful monitoring.
  • Respiratory conditions: Patients with sleep apnea, chronic obstructive pulmonary disease, or other breathing disorders should use temazepam with extreme caution due to risk of respiratory depression.
  • Substance abuse history: Individuals with a history of alcohol or drug abuse face higher risk of developing dependence and should be closely monitored.
  • Liver and kidney impairment: Patients with hepatic or renal dysfunction may require dose adjustments and more frequent monitoring due to altered drug metabolism and elimination.

Interactions

  • Alcohol: Significantly increases sedation and respiratory depression risk; concurrent use should be avoided completely.
  • Opioid medications: Combination greatly increases risk of severe sedation, respiratory depression, and potentially fatal overdose.
  • Other benzodiazepines: Concurrent use amplifies sedative effects and increases risk of excessive central nervous system depression.
  • Antihistamines: Medications like diphenhydramine can enhance drowsiness and cognitive impairment when combined with temazepam.
  • Barbiturates: Increase sedative effects and may lead to dangerous levels of central nervous system depression.
  • Antidepressants: Some antidepressants, particularly tricyclics and MAO inhibitors, can enhance temazepam’s sedative effects.
  • Muscle relaxants: Combination may result in excessive muscle weakness and increased fall risk.
  • St. John’s Wort: This herbal supplement may reduce temazepam effectiveness by increasing its metabolism.

Check interactions with the GMJ Interaction Checker

Dosage

For adults, the typical starting dose of temazepam is 15 mg taken orally 30 minutes before bedtime. The dose may be adjusted based on individual response, with a usual range of 7.5 mg to 30 mg per night. Elderly patients typically start with 7.5 mg due to increased sensitivity. Treatment should generally be limited to 7-10 days, and the medication should be taken only when a full night’s sleep (7-8 hours) is possible. Dosage must always be determined and adjusted by a qualified healthcare provider based on individual patient factors and response to treatment.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Temazepam." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/temazepam/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Traditional Chinese herb shows promise for androgenetic alopecia treatment

Traditional Chinese herb Polygonum multiflorum shows promise for treating androgenetic alopecia through…

Dual Doctor Couples Face Amplified Childcare Crisis in Medical Training

Dual doctor couples face amplified childcare challenges during medical training, with foundation…

Child Mortality Progress Stalls: 60 Countries Risk Missing 2030 UN Targets

New BMJ analysis reveals 60 countries unlikely to meet UN child survival…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Oxazepam

By
Prof. Giorgi Pkhakadze
02/06/2026

Lorazepam

By
Prof. Giorgi Pkhakadze
02/06/2026

Midazolam

By
Prof. Giorgi Pkhakadze
02/06/2026

Clonazepam

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up